US55285N1090 - Common Stock
Management to Host Conference Call Today at 4:30 p.m. ET
Management to Host Conference Call Today at 4:30 p.m. ET...
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. bioindustrial manufacturing innovations and workforce development
Project is part of the U.S. Department of Defense’s BioMADE initiative to support U.S. ...
Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching...
Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to...
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional...
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC"
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol
Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”
Shares to Begin Trading on NASDAQ on November 12, 2024, Under the Ticker Symbol “IZTC”...
Addison, TX, Oct. 16, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching...
MDB Capital Holdings just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MDB Capital Holdings (NASDAQ:MDBH) just reported results for the second quarter...
Record date of July 22, 2024 set for allocation preferences Closing and trading expected on NASDAQ on or before August 15 Addison, Texas,...
Transformative Innovations in MASH Diagnostics Dallas, Texas, July 09, 2024 (GLOBE NEWSWIRE) -- PatentVest, the first integrated IP...
ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and know-how agreement with Mayo Clinic to develop a small molecule anti-senescence platform. This collaboration aims to advance research in longevity and age-related disease prevention.
Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB Capital”), a public venture platform focused on...
56% increase in global patent publications over the last five years signals growing interest in the cardiac monitoring market which is expected to...
Addison, TX, May 22, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching...
MDB Capital Holdings just reported results for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MDB Capital Holdings (NASDAQ:MDBH) just reported results for the first quarter ...
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exitsAdditional...
Management to Host Zoom Webinar Today at 4:30 p.m. ET
Management to Host Zoom Webinar Today at 4:30 p.m. ET...
Addison, Texas, April 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform with the objective of...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips MDB Capital Holdings (NASDAQ:MDBH) just reported results for the fourth quarter...